Costa-Veiga, AnaViegas, Susana2021-02-262021-02-262019-09Costa-Veiga A, Viegas S. Occupational exposure to monoclonal antibodies in Portuguese health units: are there reasons for concern? In: EUROTOX 2019, Helsinki (Finland), September 11-19, 2019. Toxicol Lett. 2019;314 Suppl 1:s228.http://hdl.handle.net/10400.21/12980Background: The use of monoclonal antibodies (MABs) has been increasing in healthcare, namely, in the treatment of malignant and non-malignant diseases. These molecules are widely used in monotherapy and in chemotherapy cycles along with cytotoxic drugs. Currently, the use is also increasing in veterinary practice. Thus, a considerable number of health professionals (e.g. pharmacists and pharmacy technicians, nurses, veterinarians, physicians, and others) can be exposed to this new therapeutic class. Aim: To give an overview of the main guidelines to safe handling of MABs worldwide; To estimate the occupational risk of handling MABs in three Portuguese health institutions.engOccupational healthOccupational exposureMonoclonal bodiesHealth institutionPortugalconference object